Method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value 15.65% · OPTIONAL
· Pharmaceutical Preparations
RESEARCH SNAPSHOTAMARIN CORP PLC\UK's latest supported as-filed period reports revenue of $42.2M; gross margin moved 3372 basis points lower on the same comparison basis. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value 15.65% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value -41.97% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 388.70% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 35.51% · CORE
Level · gp.fundamentals.operating_margin
Raw value -28.45% · CORE
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 11.31% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed -2.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Gross margin changed -3372 basis points from the comparable as-filed period.
Gross profit changed -70.2% from the comparable as-filed period.
Each point keeps the date investors could first observe it and its accession.
AMRN · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001193125-26-330669SEC ↗10-QJul 29, 2026Period Jun 30, 20260001193125-26-323845SEC ↗8-KJul 29, 2026Period Jul 29, 20260001193125-26-323841SEC ↗4Jul 15, 2026Period Jul 1, 20260001193125-26-304914SEC ↗4Jul 15, 2026Period Jul 1, 20260001193125-26-304912SEC ↗4Jul 15, 2026Period Jul 1, 20260001193125-26-304911SEC ↗4Jul 15, 2026Period Jul 1, 20260001193125-26-304910SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Aug 1, 2026Filed Aug 3, 2026 | Fishman Peter L.SVP, CFO | Option ExerciseDirect | 313 | — | — | Form 4 ↗ |
| Aug 1, 2026Filed Aug 3, 2026 | Fishman Peter L.SVP, CFO | Tax WithholdingDirect | 155 | $14 | $2,210 | Form 4 ↗ |
| Aug 1, 2026Filed Aug 3, 2026 | Fishman Peter L.SVP, CFO | Grant Or AwardDirect | 313 | $0 | $0 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Raw value 4.97% · OPTIONAL
Inventory changed -4.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Net income changed +45.9% from the comparable as-filed period.
Operating income changed +24.9% from the comparable as-filed period.
Operating margin changed -648 basis points from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001193125-26-290834